| 000 | 01323 a2200349 4500 | ||
|---|---|---|---|
| 005 | 20250514200205.0 | ||
| 264 | 0 | _c20050721 | |
| 008 | 200507s 0 0 eng d | ||
| 022 | _a1744-7658 | ||
| 024 | 7 |
_a10.1517/13543784.13.9.1207 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aBuckheit, Robert W | |
| 245 | 0 | 0 |
_aThe 17th International Conference on Antiviral Research. _h[electronic resource] |
| 260 |
_bExpert opinion on investigational drugs _cSep 2004 |
||
| 300 |
_a1207-12 p. _bdigital |
||
| 500 | _aPublication Type: Congress | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAntiviral Agents _xtherapeutic use |
| 650 | 0 | 4 |
_aHIV Infections _xdrug therapy |
| 650 | 0 | 4 |
_aHepacivirus _xdrug effects |
| 650 | 0 | 4 |
_aHepatitis B _xdrug therapy |
| 650 | 0 | 4 |
_aHepatitis B virus _xdrug effects |
| 650 | 0 | 4 |
_aHepatitis C _xdrug therapy |
| 650 | 0 | 4 |
_aHerpesviridae _xdrug effects |
| 650 | 0 | 4 |
_aHerpesviridae Infections _xdrug therapy |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aResearch _xtrends |
| 650 | 0 | 4 |
_aSevere acute respiratory syndrome-related coronavirus _xdrug effects |
| 650 | 0 | 4 |
_aSevere Acute Respiratory Syndrome _xdrug therapy |
| 773 | 0 |
_tExpert opinion on investigational drugs _gvol. 13 _gno. 9 _gp. 1207-12 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1517/13543784.13.9.1207 _zAvailable from publisher's website |
| 999 |
_c15028379 _d15028379 |
||